Biosecurity Modernization and Innovation Act of 2026 aims to enhance nucleic acid synthesis security and streamline biosecurity and biosafety.

The Biosecurity Modernization and Innovation Act of 2026 mandates the Secretary of Commerce to establish regulations for covered providers, requiring them to implement screening protocols for sequences of concern. It also requires the creation of a list of sequences of concern, a conformity assessment system, and a biotechnology governance sandbox. The Act emphasizes the importance of consolidating biosecurity and biosafety guidelines and authorities across federal agencies to ensure effective oversight.

Biosecurity Modernization and Innovation Act of 2026 aims to enhance nucleic acid synthesis security and streamline biosecurity and biosafety.

The Biosecurity Modernization and Innovation Act of 2026 mandates the Secretary of Commerce to establish regulations for covered providers, requiring them to implement screening protocols for sequences of concern. It also requires the creation of a list of sequences of concern, a conformity assessment system, and a biotechnology governance sandbox. The Act emphasizes the importance of consolidating biosecurity and biosafety guidelines and authorities across federal agencies to ensure effective oversight.